Detection of Inflammatory Biomarkers Among Patients with Sepsis of Gram-Negative Bacteria: A Cross-Sectional Study

References

• Liu J, Bai C, Li B, et al. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units. Sci Rep. 2021;11(1):1275. doi:10.1038/s41598-020-79843-5
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ismaeel SM, Mohammed DA, et al. Outcome and management of sepsis at Rozhhalat emergency hospital in Erbil –Kurdistan region of Iraq. J Appl Res. 2018;2018:21–30.
   Google Scholar
• Gudiol C, Albasanz-Puig A, Cuervo G, et al. Understanding and managing sepsis in patients with cancer in the era of antimicrobial resistance. Front Med. 2021;8:636547. doi:10.3389/fmed.2021.636547
   Web of Science ®Google Scholar
• Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121–137. doi:10.1038/nrneph.2017.165
   PubMed Web of Science ®Google Scholar
• Hung Y-L, Suzuki K. The pattern recognition receptors and lipopolysaccharides (LPS)-induced systemic inflammation. Int J Med Sci Public Health. 2017;2(7):1–7.
   Google Scholar
• Zamyatina A, Heine H. Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4/11 mediated inflammatory pathways. Front Immunol. 2020;11:585146. doi:10.3389/fimmu.2020.585146
   PubMed Web of Science ®Google Scholar
• Xu C, Li S, Wang Y, et al. Biomarkers in intensive care unit infections, friend or foe? J Emerg Crit Care Med. 2019;3:27. doi:10.21037/jeccm.2019.06.02
   Google Scholar
• Xue M, Xu F, Yang Y, et al. Diagnosis of sepsis with inflammatory biomarkers, cytokines, endothelial functional markers from SIRS patients. Medicine. 2022;101(7):e28681. doi:10.1097/MD.0000000000028681
   PubMed Web of Science ®Google Scholar
• Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, et al. Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial. Am J Respir Crit Care Med. 2021;203(2):202–210. doi:10.1164/rccm.202004-1201OC
   PubMed Web of Science ®Google Scholar
• Ryoo SM, Han KS, Ahn S, et al. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: a multicenter prospective registry-based observational study. Sci Rep. 2019;9(1):6579. doi:10.1038/s41598-019-42972-7
   PubMedGoogle Scholar
• Hamed S, Behnes M, Pauly D, et al. Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions. BMC Infect Dis. 2017;17(1):554. doi:10.1186/s12879-017-2606-3
   PubMedGoogle Scholar
• Geven C, Kox M, Pickkers P. Adrenomedullin and adrenomedullin-targeted therapy as treatment strategies relevant for sepsis. Front Immunol. 2018;9:292. doi:10.3389/fimmu.2018.00292
   PubMed Web of Science ®Google Scholar
• van Lier D, Kox M, Pickkers P. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3. J Intern Med. 2021;289(6):792–806. doi:10.1111/joim.13220
   PubMed Web of Science ®Google Scholar
• Ge Y, Huang M, Yao YM. Biology of interleukin-17 and its pathophysiological significance in sepsis. Front Immunol. 2020;11:1558. doi:10.3389/fimmu.2020.01558
   PubMed Web of Science ®Google Scholar
• Chen KF, Chaou C-H, Jiang J-Y, et al. Diagnostic accuracy of lipopolysaccharide-binding protein as biomarker for sepsis in adult patients: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0153188. doi:10.1371/journal.pone.0153188
   PubMed Web of Science ®Google Scholar
• Fuchs A, Tufa TB, Hörner J, et al. Clinical and microbiological characterization of sepsis and evaluation of sepsis scores. PLoS One. 2021;16(3):e0247646. doi:10.1371/journal.pone.0247646
   PubMed Web of Science ®Google Scholar
• Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology E-Book. Elsevier Health Sciences; 2020.
   Google Scholar
• Melvin P, James S, April M; CLSI. Performance standards for antimicrobial susceptibility testing. In: CLSI Supplement M100. 30 ed. PA: Wayne: C.A.L.S. Institute; 2020.
   Google Scholar
• Rajivgandhi G, Maruthupandy M, Ramachandran G, et al. Detection of ESBL genes from ciprofloxacin resistant Gram negative bacteria isolated from urinary tract infections (UTIs). Front Lab Med. 2018;2(1):5–13. doi:10.1016/j.flm.2018.01.001
   Google Scholar
• Teklu DS, Negeri AA, Legese MH, et al. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8(1):39. doi:10.1186/s13756-019-0488-4
   PubMed Web of Science ®Google Scholar
• Naseer F. Phenotypic Cofirmatory Disc Diffusion Test (PCDDT), Double Disc Synergy Test (DDST), E-Test Os Diagnostic Tool for Detection of Extended Spectrum Beta Lactamase (ESΒL) Producing Uropathogens. J Appl Biotechnol Bioeng. 2017;3(3):344–349. doi:10.15406/jabb.2017.03.00068
   Google Scholar
• Luhr R, Cao Y, Söderquist B, et al. Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002–2016. Crit Care. 2019;23(1):1–9. doi:10.1186/s13054-019-2528-0
   PubMedGoogle Scholar
• Xu J, Tong L, Yao J, et al. Association of sex with clinical outcome in critically ill sepsis patients: a retrospective analysis of the large clinical database MIMIC-III. Shock. 2019;52(2):146–151. doi:10.1097/SHK.0000000000001253
   PubMed Web of Science ®Google Scholar
• Te Marvelde L, Whitfield A, Shepheard J, et al. Epidemiology of sepsis in cancer patients in Victoria, Australia: a population‐based study using linked data. Aust N Z J Public Health. 2020;44(1):53–58. doi:10.1111/1753-6405.12935
   PubMed Web of Science ®Google Scholar
• Lewis JM, Feasey NA, Rylance J. Aetiology and outcomes of sepsis in adults in sub-Saharan Africa: a systematic review and meta-analysis. Crit Care. 2019;23(1):1–11. doi:10.1186/s13054-019-2501-y
   PubMed Web of Science ®Google Scholar
• Aljanaby AAJ, Aljanaby IAJ. Prevalence of aerobic pathogenic bacteria isolated from patients with burn infection and their antimicrobial susceptibility patterns in Al-Najaf City, Iraq-a three-year cross-sectional study. F1000 Res. 2018;7(1157):1157. doi:10.12688/f1000research.15088.1
   Google Scholar
• Emami A, Pirbonyeh N, Keshavarzi A, et al. Three year study of infection profile and antimicrobial resistance pattern from burn patients in southwest Iran. Infect Drug Resist. 2020;13:1499–1506. doi:10.2147/IDR.S249160
   PubMed Web of Science ®Google Scholar
• Mansouri S, Razavi M, Norouzi F, et al. Prevalence of β-Lactamase production and antimicrobial susceptibility of multidrug resistant clinical isolates of non-fermenting Gram negative bacteria from hospitalized patients in Kerman/Iran. Jundishapur J Microbiol. 2012;5(2):405–410. doi:10.5812/jjm.3399
   Web of Science ®Google Scholar
• Kakoullis L, Papachristodoulou E, Chra P, et al. Mechanisms of antibiotic resistance in important gram-positive and gram-negative pathogens and novel antibiotic solutions. Antibiotics. 2021;10(4):415. doi:10.3390/antibiotics10040415
   Google Scholar
• Munita JM, Arias CA, Kudva IT, Zhang Q. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4(2):1–15. doi:10.1128/microbiolspec.VMBF-0016-2015
   Web of Science ®Google Scholar
• Pana ZD, Zaoutis T. Treatment of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now? F1000 Res. 2018;7:1–9. doi:10.12688/f1000research.14822.1
   Google Scholar
• Swaminathan S, Routray A, Mane A. Early and appropriate use of ceftazidime-avibactam in the management of multidrug-resistant gram-negative bacterial infections in the Indian scenario. Cureus. 2022;14(8):e28283. doi:10.7759/cureus.28283
   PubMed Web of Science ®Google Scholar
• Rios-Toro JJ, Márquez-Coello M, García-álvarez J-M, et al. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS One. 2017;12(4):e0175254. doi:10.1371/journal.pone.0175254
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang W, Hou W, et al. The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection. Front Public Health. 2022;10:923457. doi:10.3389/fpubh.2022.923457
   PubMed Web of Science ®Google Scholar
• Piccioni A, Saviano A, Cicchinelli S, et al. Proadrenomedullin in sepsis and septic shock: a role in the emergency department. Medicina. 2021;57(9):920. doi:10.3390/medicina57090920
   PubMedGoogle Scholar
• Wang L, Zhao H, Wang D. Inflammatory cytokine expression in patients with sepsis at an intensive care unit. Exp Ther Med. 2018;16(3):2126–2131. doi:10.3892/etm.2018.6376
   PubMed Web of Science ®Google Scholar
• Vijayan AL, Saikant R, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5(1):51. doi:10.1186/s40560-017-0246-8
   PubMedGoogle Scholar
• Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287. doi:10.1186/s13054-020-02993-5
   PubMed Web of Science ®Google Scholar
• Teggert A, Datta H, Ali Z. Biomarkers for point-of-care diagnosis of sepsis. Micromachines. 2020;11(3):286. doi:10.3390/mi11030286
   PubMed Web of Science ®Google Scholar
• Tian R, Wang X, Pan T, et al. Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock. Scand J Immunol. 2019;90(6):e12823. doi:10.1111/sji.12823
   PubMed Web of Science ®Google Scholar
• Youness E, Nahla A. Clinical role of serum lactic dehydrogenase assessment in critically ill pediatric patients with sepsis. Med J Cairo Univ. 2021;89(September):1917–1927. doi:10.21608/mjcu.2021.203303
   Google Scholar